Literature DB >> 34306477

Application of CT and MRI combined with VEGF-C and EGFR in the identification of endometrial cancer stages.

Changsong Li1, Jingsheng Yu2, Zhexiang Fu1.   

Abstract

OBJECTIVE: To explore the application of computed tomography (CT) and magnetic resonance imaging (MRI) in combination with vascular endothelial growth factor-C (VEGF-C) and epidermal growth factor receptor (EGFR) in the identification of endometrial cancer stages.
METHODS: Clinical data of 84 patients with endometrial cancer who underwent surgery in our hospital were retrospectively analyzed. Before surgery, they were received inspection by CT and MRI and examination by VEGF-C and EGFR measurement. The pathological results after surgery were used as the gold standard, which was applied to compare the diagnostic accuracy of endometrial cancer stages by CT, MRI, and CT+MRI and to analyze how VEGF-C and EGFR expression and CT+MRI diagnosis correlated with relevant pathological parameters.
RESULTS: Using pathological results as the gold standard, the diagnostic accuracy of endometrial cancer stages via CT+MRI combined with VEGF-C+EGFR immunostaining was significantly higher (96.43%) compared with CT+MRI, CT, and MRI (91.67%, 70.24%, and 77.38%, respectively) (P<0.05). The positive rates of VEGF-C and EGFR expression in patients with different endometrial cancer stages identified by CT+MRI were significantly different (P<0.05). Spearman's rank correlation coefficient showed that the positive rates of VEGF-C and EGFR expression were both positively correlated with CT+MRI identified stages (r>0, P<0.05). The accuracy of CT+MRI diagnosed lymph node metastasis, myometrial infiltration, and interstitial infiltration was 90.48%, 92.86%, and 84.52%, respectively. The positive rates of VEGF-C and EGFR expression were significantly higher by lymph node metastasis compared with non-metastasis; the positive rates of VEGF-C and EGFR expression were significantly higher by deep myometrial infiltration compared with superficial infiltration; the positive rates of VEGF-C and EGFR expression were significantly higher by interstitial infiltration compared with no interstitial infiltration (P<0.05).
CONCLUSION: CT and MRI combined with VEGF-C and EGFR can effectively identify endometrial cancer stages. AJTR
Copyright © 2021.

Entities:  

Keywords:  Endometrial cancer; computed tomography; epidermal growth factor receptor; magnetic resonance imaging; stage; vascular endothelial growth factor-C

Year:  2021        PMID: 34306477      PMCID: PMC8290686     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  20 in total

1.  The diagnostic value of multimodality MRI in endometrial carcinoma staging.

Authors:  Lixin Du; Yongqiang Yu; Yuli Wang; Jun Xia; Xixiong Qiu; Yi Lei
Journal:  Acta Radiol       Date:  2016-10-22       Impact factor: 1.990

2.  Diagnostic efficacy of MRI for pre-operative assessment of ovarian malignancy in endometrial carcinoma: A decision tree analysis.

Authors:  Xiaojuan Xu; Nan Li; Yan Chen; Han Ouyang; Xinming Zhao; Jing Zhou
Journal:  Magn Reson Imaging       Date:  2018-12-21       Impact factor: 2.546

3.  The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.

Authors:  Y Naaman; L Pinkas; S Roitman; S Ikher; N Oustinov; E Vaisbuch; A Yachnin; A Ben-Arie
Journal:  Ann Surg Oncol       Date:  2015-10-05       Impact factor: 5.344

4.  Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.

Authors:  Hiroaki Takagi; Toshiyuki Sasagawa; Takeo Shibata; Hiroshi Minato; Tomoko Takahashi
Journal:  Taiwan J Obstet Gynecol       Date:  2018-04       Impact factor: 1.705

Review 5.  Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.

Authors:  Oluwole Fadare; Vinita Parkash
Journal:  Surg Pathol Clin       Date:  2019-06

Review 6.  Imaging and Staging of Endometrial Cancer.

Authors:  S C Faria; C E Devine; B Rao; T Sagebiel; P Bhosale
Journal:  Semin Ultrasound CT MR       Date:  2019-04-18       Impact factor: 1.875

7.  Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.

Authors:  Preetha Ramalingam; Ramya P Masand; Elizabeth D Euscher; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2016-09       Impact factor: 2.762

Review 8.  The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology.

Authors:  Sherelle L Laifer-Narin; Wendy F Genestine; Nancy C Okechukwu; Elizabeth M Hecht; Jeffrey H Newhouse
Journal:  PET Clin       Date:  2018-01-10

Review 9.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Authors:  Stephanie Nougaret; Mariana Horta; Evis Sala; Yulia Lakhman; Isabelle Thomassin-Naggara; Aki Kido; Gabriele Masselli; Nishat Bharwani; Elizabeth Sadowski; Andrea Ertmer; Milagros Otero-Garcia; Rahel A Kubik-Huch; Teresa M Cunha; Andrea Rockall; Rosemarie Forstner
Journal:  Eur Radiol       Date:  2018-07-11       Impact factor: 5.315

Review 10.  Primary squamous cell carcinoma of endometrium: case report and literature review.

Authors:  Fatima Zahra Farhane; Zineb Alami; Touria Bouhafa; Abderrahmane Elmazghi; Khalid Hassouni
Journal:  Pan Afr Med J       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.